RCAMU
OFIX icon

Rothschild & Co Asset Management US’s Orthofix Medical OFIX Stock Holding History

Rothschild & Co Asset Management US’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,336
Closed -$430K – 338
2020
Q1 		$430K Sell
15,336
-230,988
-94% -$8.93M 0.01% 313
2019
Q4 		$11.4M Sell
246,324
-18,906
-7% -$889K 0.12% 246
2019
Q3 		$14.1M Buy
265,230
+28,728
+12% +$1.48M 0.15% 222
2019
Q2 		$12.5M Buy
236,502
+6,413
+3% +$341K 0.13% 234
2019
Q1 		$13M Buy
230,089
+8,034
+4% +$451K 0.14% 229
2018
Q4 		$11.7M Buy
222,055
+10,981
+5% +$625K 0.14% 234
2018
Q3 		$12.2M Buy
+211,074
New +$11.8M 0.13% 253

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Rothschild & Co Asset Management US's OFIX Position: Q2 2020 in Review

Rothschild & Co Asset Management US sold out of Orthofix Medical (OFIX) in Q2 2020, closing a stake of 15,336 shares — an estimated $430K sold.

Rothschild & Co Asset Management US first reported a position in OFIX in Q3 2018 and held it in 7 quarters. The position peaked at $14.1M in Q3 2019. 140 funds tracked by Wall St. Rank hold OFIX as of Q2 2020.

  • Rothschild & Co Asset Management US reported no remaining Orthofix Medical position as of Q2 2020 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 15,336 Orthofix Medical shares in Q2 2020, an estimated $430K.
  • Rothschild & Co Asset Management US first reported a position in Orthofix Medical in Q3 2018 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's Orthofix Medical position peaked at $14.1M in Q3 2019.
  • 140 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.